Revenue (Quarterly) Chart

Historical Revenue (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 40.23M
March 31, 2026 35.22M
December 31, 2025 48.57M
September 30, 2025 48.19M
June 30, 2025 47.94M
March 31, 2025 34.91M
December 31, 2024 42.13M
September 30, 2024 36.58M
June 30, 2024 37.13M
March 31, 2024 40.06M
December 31, 2023 36.93M
September 30, 2023 44.63M
June 30, 2023 71.91M
March 31, 2023 31.77M
December 31, 2022 32.94M
September 30, 2022 33.30M
June 30, 2022 32.51M
March 31, 2022 33.82M
December 31, 2021 27.73M
September 30, 2021 27.90M
June 30, 2021 23.70M
March 31, 2021 36.50M
December 31, 2020 26.99M
September 30, 2020 24.24M
June 30, 2020 20.97M
Date Value
March 31, 2020 19.51M
December 31, 2019 19.43M
September 30, 2019 17.84M
June 30, 2019 16.78M
March 31, 2019 14.30M
December 31, 2018 12.43M
September 30, 2018 13.08M
June 30, 2018 10.50M
March 31, 2018 9.348M
December 31, 2017 10.50M
September 30, 2017 6.774M
June 30, 2017 3.254M
March 31, 2017 3.084M
December 31, 2016 4.350M
September 30, 2016 2.798M
June 30, 2016 2.172M
March 31, 2016 2.690M
September 30, 2015 1.977M
June 30, 2015 2.100M
March 31, 2015 1.952M
December 31, 2014 1.745M
September 30, 2014 1.228M
June 30, 2014 0.897M
March 31, 2014 0.5423M
December 31, 2013 0.5882M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
3-D Matrix Ltd. 20.10M
Healios KK 0.0439M
AnGes, Inc. 1.876M
ACADIA Pharmaceuticals, Inc. 307.96M
Alkermes Plc 496.01M